BNTX logo

BioNTech SE (BNTX) Cash and cash equivalents

annual cash & cash equivalents:

$10.16B-$2.74B(-21.21%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BNTX annual cash & cash equivalents is $10.16 billion, with the most recent change of -$2.74 billion (-21.21%) on December 31, 2024.
  • During the last 3 years, BNTX annual cash & cash equivalents has risen by +$8.24 billion (+430.02%).
  • BNTX annual cash & cash equivalents is now -31.73% below its all-time high of $14.88 billion, reached on December 31, 2022.

Performance

BNTX Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXbalance sheet metrics

quarterly cash & cash equivalents:

$11.02B+$865.48M(+8.52%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX quarterly cash & cash equivalents is $11.02 billion, with the most recent change of +$865.48 million (+8.52%) on March 1, 2025.
  • Over the past year, BNTX quarterly cash & cash equivalents has increased by +$1.33 billion (+13.72%).
  • BNTX quarterly cash & cash equivalents is now -28.40% below its all-time high of $15.40 billion, reached on June 30, 2023.

Performance

BNTX quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

BNTX Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-21.2%+13.7%
3 y3 years+430.0%+60.2%
5 y5 years+1646.8%+2113.2%

BNTX Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-31.7%+430.0%-28.4%+60.2%
5 y5-year-31.7%+1646.8%-28.4%+2113.2%
alltimeall time-31.7%+4819.7%-28.4%+3303.1%

BNTX Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$11.02B(+8.5%)
Dec 2024
$10.16B(-21.2%)
$10.16B(-5.5%)
Sep 2024
-
$10.75B(-3.4%)
Jun 2024
-
$11.12B(+14.7%)
Mar 2024
-
$9.69B(-24.8%)
Dec 2023
$12.89B(-13.4%)
$12.89B(-9.7%)
Sep 2023
-
$14.29B(-7.2%)
Jun 2023
-
$15.40B(+16.3%)
Mar 2023
-
$13.24B(-11.0%)
Dec 2022
$14.88B(+676.4%)
$14.88B(+12.8%)
Sep 2022
-
$13.19B(+35.3%)
Jun 2022
-
$9.75B(+41.7%)
Mar 2022
-
$6.88B(+259.0%)
DateAnnualQuarterly
Dec 2021
$1.92B(+28.8%)
$1.92B(-30.9%)
Sep 2021
-
$2.78B(+155.1%)
Jun 2021
-
$1.09B(+4.1%)
Mar 2021
-
$1.05B(-29.8%)
Dec 2020
$1.49B(+156.0%)
$1.49B(+28.0%)
Sep 2020
-
$1.16B(+80.4%)
Jun 2020
-
$644.45M(+29.4%)
Mar 2020
-
$498.08M(-14.4%)
Dec 2019
$581.54M(+23.5%)
$581.54M(+14.7%)
Sep 2019
-
$506.91M(+56.5%)
Jun 2019
-
$323.92M(-31.2%)
Dec 2018
$470.71M(+128.0%)
$470.71M
Dec 2017
$206.48M(-35.7%)
-
Dec 2016
$321.04M
-

FAQ

  • What is BioNTech SE annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for BioNTech SE?
  • What is BioNTech SE annual cash & cash equivalents year-on-year change?
  • What is BioNTech SE quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for BioNTech SE?
  • What is BioNTech SE quarterly cash & cash equivalents year-on-year change?

What is BioNTech SE annual cash & cash equivalents?

The current annual cash & cash equivalents of BNTX is $10.16B

What is the all time high annual cash & cash equivalents for BioNTech SE?

BioNTech SE all-time high annual cash & cash equivalents is $14.88B

What is BioNTech SE annual cash & cash equivalents year-on-year change?

Over the past year, BNTX annual cash & cash equivalents has changed by -$2.74B (-21.21%)

What is BioNTech SE quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of BNTX is $11.02B

What is the all time high quarterly cash & cash equivalents for BioNTech SE?

BioNTech SE all-time high quarterly cash & cash equivalents is $15.40B

What is BioNTech SE quarterly cash & cash equivalents year-on-year change?

Over the past year, BNTX quarterly cash & cash equivalents has changed by +$1.33B (+13.72%)
On this page